Breaking News Instant updates and real-time market news.

CB

Chubb

$133.41

-1.56 (-1.16%)

, SWCH

Switch

$10.24

-3.72 (-26.65%)

10:16
08/14/18
08/14
10:16
08/14/18
10:16

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Chubb (CB) downgraded to Sell from Hold at Deutsche Bank with analyst Joshua Shanker saying the company's recent quarterly results show that Chubb, post-merger, is unable to grow its business at the levels of its peers. 2. Switch (SWCH) was downgraded to Market Perform from Outperform at Raymond James, to Neutral from Overweight at JPMorgan, and to Neutral from Buy at BTIG. 3. Urban Outfitters (URBN) downgraded to Neutral from Outperform at Baird with analyst Mark Altschwager citing valuation. 4. Premier (PINC) downgraded to Hold from Buy at Canaccord with analyst Richard Close citing its quarter-to-date outperformance. 5. Parker-Hannifin (PH) downgraded to Hold from Buy at Argus with analyst John Eade saying that while the company's recent Q4 results topped expectations, management's outlook for FY19 was worse than expected. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

CB

Chubb

$133.41

-1.56 (-1.16%)

SWCH

Switch

$10.24

-3.72 (-26.65%)

URBN

Urban Outfitters

$47.09

-0.33 (-0.70%)

PINC

Premier

$37.46

-0.99 (-2.57%)

PH

Parker-Hannifin

$166.69

-0.555 (-0.33%)

  • 21

    Aug

  • 21

    Aug

  • 14

    Sep

CB Chubb
$133.41

-1.56 (-1.16%)

08/13/18
DBAB
08/13/18
DOWNGRADE
Target $126
DBAB
Sell
Chubb downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Joshua Shanker downgraded Chubb to Sell and lowered his price target for the shares to $126 from $135. The stock closed the trading day down 92c to $134.98.
08/07/18
FBCO
08/07/18
INITIATION
Target $141
FBCO
Neutral
Travelers initiated with a Neutral at Credit Suisse
Credit Suisse analyst Michael Zaremski started Travelers (TRV) with a Neutral rating and $141 price target. For shorter-term oriented investors, the analyst recommends Travelers over peer Chubb (CB) due to having more conviction over its recent string of higher than expected non-catastrophe weather-related losses subsiding, a greater gearing to workers' comp. leading to a steady stream of reserve releases given an extremely healthy unemployment backdrop, and conviction that near-term auto margins will continue to improve given industry pricing dynamics. In the longer term, he struggles to make the case that Travelers' wheels business can produce better and less volatile results.
08/07/18
FBCO
08/07/18
INITIATION
Target $150
FBCO
Neutral
Chubb initiated with a Neutral at Credit Suisse
Credit Suisse analyst Michael Zaremski started Chubb with a Neutral rating and $150 price target. The analyst believe Chubb will continue its performance as a top quartile underwriter given it has diversified its business mix to the point where its results are not tied to any one line of business or geography's inherent P&C cyclicality. However, he foresees margins on an absolute basis declining marginally through 2020 owing to diminished reserve release prospects in large commercial liability lines
08/13/18
DBAB
08/13/18
DOWNGRADE
Target $126
DBAB
Sell
Deutsche Bank downgrades Chubb to Sell with $126 price target
Deutsche Bank analyst Joshua Shanker downgraded Chubb to Sell and lowered his price target for the shares to $126 from $135. The company's recent quarterly results show that Chubb, post-merger, is unable to grow its business at the levels of its peers, Shanker tells investors in a research note. Further, the analyst believes the company is unlikely to maintain its current underwriting margins and that consensus estimates will need to be revised downward.
SWCH Switch
$10.24

-3.72 (-26.65%)

08/14/18
BTIG
08/14/18
DOWNGRADE
BTIG
Neutral
Switch downgraded to Neutral from Buy at BTIG
BTIG analyst Edward Parker downgraded Switch to Neutral after its Q2 earnings miss and reduced FY18 guidance attributed to the timing of several large deals closing later than expected. The analyst notes that while the management cites customers taking more time to evaluate the design of their hybrid cloud infrastructure in making the decision to upgrade, he is "unclear" on why the upgrade to the "elite hybrid offering" is necessary from Switch's existing offerings, even though he maintains his view that the company provides "differentiated technology". Longer term, Parker states that Switch stock needs to "find a floor" and for the company to deliver more consistent results to regain investor confidence.
08/14/18
SBSH
08/14/18
NO CHANGE
Target $16
SBSH
Buy
Switch Buy thesis 'mostly intact' after guide-down, says Citi
Citi analyst Michael Rollins keeps a Buy rating on Switch after the company reduced its 2018 guidance on lengthening sales and install cycles. The analyst believes his thesis is still "mostly intact" given the "underlying value of the core campus" and Switch's financial flexibility to improve shareholder returns. The analyst has a $16 price target for the shares.
08/14/18
JEFF
08/14/18
NO CHANGE
Target $12
JEFF
Hold
Switch price target lowered to $12 from $15 at Jefferies
Jefferies analyst Scott Goldman lowered his price target for Switch to $12 saying the magnitude of the guidance cut is surprising, and implies virtually no incremental growth in the second half of 2018. The analyst is inclined to believe the outlook is conservative, but adds that "visibility is weak and the track record spotty." He maintains a Hold rating on shares of Switch.
08/14/18
BMOC
08/14/18
NO CHANGE
Target $14
BMOC
Outperform
Switch price target lowered to $14 from $20 at BMO Capital
BMO Capital analyst Tim Long lowers his price target on Switch to $14 after its Q2 earnings miss and reduced FY18 outlook, saying that the lack of visibility is weighing on the stock. Long keeps his Outperform rating however, noting that Switch's total contract value remained "impressive". The analyst also states that its new valuation implies a 15% discount to the Data Center REIT average, which is too low after the company's expectations have been reset.
URBN Urban Outfitters
$47.09

-0.33 (-0.70%)

08/14/18
BARD
08/14/18
DOWNGRADE
BARD
Neutral
Urban Outfitters downgraded to Neutral on valuation at Baird
Baird analyst Mark Altschwager downgraded Urban Outfitters to Neutral from Outperform citing valuation and maintained a $53 price target.
07/13/18
WEDB
07/13/18
INITIATION
Target $50
WEDB
Neutral
Urban Outfitters a 'compelling' turnaround story, says Wedbush
Wedbush analyst Jen Redding initiated shares of Urban Outfitters with a Neutral rating and $50 price target, telling investors in a research note that she views Urban as a "compelling" turnaround story with meaningful multi-year runway ahead driven by gross margin expansion and revenue growth. Still, Redding says she is on the sidelines with a Neutral, as shares trade a distance of about 9% from the 52-week high which sits at $48.24, and holds concerns over if short-term expectations into print have run up too much at this point in the quarter.
07/13/18
07/13/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Galmed (GLMD) initiated with a Buy at Stifel. 2. Oshkosh (OSK) initiated with a Buy at Longbow. 3. Domo (DOMO) was initiated with a Positive at Susquehanna and an Outperform at Oppenheimer. 4. ADMA Biologics (ADMA) initiated with an Outperform at Oppenheimer. 5. Urban Outfitters (URBN) initiated with a Neutral at Wedbush and an Outperform at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/13/18
LOOP
08/13/18
NO CHANGE
Target $55
LOOP
Buy
Urban Outfitters price target raised to $55 from $50 at Loop Capital
Loop Capital analyst Laura Champine raised her price target on Urban Outfitters to $55 ahead of its earnings next week, citing "continued momentum in apparel sales", with every segment reporting SSS growth. The analyst expects that momentum to be sustained or accelerate for the rest of year, also noting less promotional activity and "conservative" expectations. Champine keeps her Buy rating on Urban Outfitters, adding that its valuation of 16-times expected forward earnings is "attractive".
PINC Premier
$37.46

-0.99 (-2.57%)

08/14/18
ADAM
08/14/18
DOWNGRADE
ADAM
Hold
Premier downgraded to Hold from Buy at Canaccord
08/14/18
ADAM
08/14/18
DOWNGRADE
Target $38
ADAM
Hold
Premier downgraded to Hold on valuation at Canaccord
As reported previously, Canaccord analyst Richard Close downgraded Premier to Hold form Buy. The analyst cited its quarter-to-date outperformance. He also believes the shares should trade at a discount to peers until a meaningful improvement in its Performance Services emerges. Close raised his price target to $38 from $37 on Premier shares.
06/27/18
LEER
06/27/18
INITIATION
Target $45
LEER
Outperform
Premier initiated with an Outperform at Leerink
Leerink analyst David Larsen started Premier with an Outperform rating and $45 price target as he believes it continues to take share, and the current valuation is attractive. The analyst expects steady top-line growth, revenue visibility remains high and the industry continues to shift to value based care.
07/16/18
OPCO
07/16/18
NO CHANGE
OPCO
Tailwinds ahead for Cerner, Premier, says Oppenheimer
Oppenheimer analyst Mohan Naidu says his survey of 49 C-level executives in hospital systems shows a high inclination toward risk-based contracting. The current level of at-risk lives is expected to grow about 2.5 times to 33% in the next five years, he notes. While at-risk programs are led by managed Medicaid contracts today, the analyst sees upside for Medicare next-generation ACOs, given recent commentary from Washington around two-sided risk. Naidu believes the expectations of increasing mix of at-risk lives will be a tailwind for pop health solutions vendors such as Cerner (CERN), Evolent Health (EVH) and Premier (PINC).
PH Parker-Hannifin
$166.69

-0.555 (-0.33%)

08/14/18
ARGS
08/14/18
DOWNGRADE
ARGS
Hold
Parker-Hannifin downgraded to Hold from Buy at Argus
08/06/18
08/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Overweight from Neutral at Atlantic Equities with analyst Hamilton Faber saying he believes "the bulk of the M&A storm" has passed. 2. Qualcomm (QCOM) upgraded to Outperform from Market Perform at Cowen with analyst Matthew Ramsay citing the company's $30B buyback and saying he believes the shares offer a compelling risk/reward with effects of lower spending, solid customer performance, and potential QTL resolutions. 3. Square (SQ) upgraded to Buy from Neutral at Buckingham with analyst Chris Brendler saying the Q2 strong results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better-then-expected core revenue growth into 2020. 4. Parker-Hannifin (PH) upgraded to Outperform from In Line at Evercore ISI with analyst David Raso saying the company's recent operational struggles are behind it with this quarters report and views 2019 guidance as conservative. 5. Intercept (ICPT) upgraded to Buy from Sell at Goldman Sachs with analyst Salveen Richter saying Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/14/18
ARGS
08/14/18
DOWNGRADE
ARGS
Hold
Parker-Hannifin downgraded to Hold at Argus on 'challenging' FY19 outlook
As reported earlier, Argus analyst John Eade downgraded Parker-Hannifin to Hold from Buy, saying that while the company's recent Q4 results topped expectations, the management's outlook for FY19 was worse than expected. The analyst warns that the uncertainty around trade and tariffs could further compress industry valuations, with the stock already falling about 5% over the past quarter. Eade states that while he is positive on Parker-Hannifin's ability to raise margins and grow earnings over the long term, the near-term trends are more "problematic".
08/06/18
EVER
08/06/18
UPGRADE
Target $196
EVER
Outperform
Parker-Hannifin upgraded to Outperform at Evercore ISI
As previously reported Evercore ISI upgraded Parker-Hannifin to Outperform from In Line and raised its price target to $196 from $187. Analyst David Raso said the company's recent operational struggles are behind it with this quarters report and views 2019 guidance as conservative. Raso also said Parker's debt reduction from the Clarcor acquisitions is occurring earlier than expected allowing management to "lean-froward" again with the use of its cash flow and balance sheet in the M&A market. The analyst believes the cycle has more duration and Parker shares should close the discount to the S&P 500, not widen it.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$17.94

-0.055 (-0.31%)

, FBNK

First Connecticut

$30.95

0.1 (0.32%)

12:47
09/22/18
09/22
12:47
09/22/18
12:47
Conference/Events
First Connecticut to host special shareholder meeting »

Special shareholder…

PBCT

People's United

$17.94

-0.055 (-0.31%)

FBNK

First Connecticut

$30.95

0.1 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 18

    Oct

ASPS

Altisource

$34.10

-0.09 (-0.26%)

12:44
09/22/18
09/22
12:44
09/22/18
12:44
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CSCO

Cisco

$48.51

0.77 (1.61%)

12:36
09/22/18
09/22
12:36
09/22/18
12:36
Periodicals
Apple, Microsoft among stocks with solid dividends, Barron's says »

Technology stocks are not…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

CAT

Caterpillar

$156.39

0.38 (0.24%)

, AMAT

Applied Materials

$39.62

0.22 (0.56%)

12:28
09/22/18
09/22
12:28
09/22/18
12:28
Periodicals
Caterpillar, KeyCorp among stocks to buy as bond yields rise, Barron's says »

As the economy improves,…

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 18

    Oct

  • 25

    Oct

  • 30

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

, ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

10:34
09/22/18
09/22
10:34
09/22/18
10:34
Periodicals
'Good time' to think about device markers, Barron's says »

Medical technology stocks…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$123.16

-53.365 (-30.23%)

10:20
09/22/18
09/22
10:20
09/22/18
10:20
Periodicals
Marijuana stocks 'the new Bitcoin,' Barron's says »

Led by Tilray, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, WMT

Walmart

$95.85

0.1 (0.10%)

09:05
09/22/18
09/22
09:05
09/22/18
09:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$217.65

-2.35 (-1.07%)

WMT

Walmart

$95.85

0.1 (0.10%)

DE

Deere

$152.82

-1.24 (-0.80%)

AGCO

Agco

$60.24

-0.9 (-1.47%)

ADM

Archer Daniels

$50.33

(0.00%)

MOS

Mosaic

$32.33

0.02 (0.06%)

CF

CF Industries

$52.82

-0.48 (-0.90%)

SPWR

SunPower

$7.88

-0.18 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 15

    Nov

  • 03

    Mar

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/22/18
09/22
04:55
09/22/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.